These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 12581957

  • 1. [Clinical study of changes of urotensin II in patients with congestive heart failure].
    Zhong P, Li ZL, Wu HC, Tang CS, Lu Q.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):121-3. PubMed ID: 12581957
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation.
    Bousette N, Hu F, Ohlstein EH, Dhanak D, Douglas SA, Giaid A.
    J Mol Cell Cardiol; 2006 Aug; 41(2):285-95. PubMed ID: 16797584
    [Abstract] [Full Text] [Related]

  • 4. [Clinical study of plasma urotensin II in patients with coronary heart disease].
    Fang SH, Li ZL, Wu HC, Tang CS, Lu Q, Liu HC, Yan QN.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):563-5. PubMed ID: 15151835
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma levels of adrenomedullin and atrial natriuretic peptide in patients with congestive heart failure of various etiologies.
    Randa Abdel Kader M, Grace BD, Badawi NE.
    Ital J Biochem; 2007 Mar; 56(1):18-27. PubMed ID: 17511350
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
    Kelly D, Squire IB, Khan SQ, Quinn P, Struck J, Morgenthaler NG, Davies JE, Ng LL.
    J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
    [Abstract] [Full Text] [Related]

  • 11. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY, Freestone B, Lim HS, Kistorp C, Gustafsson F, Hildebrandt P, Lip GY.
    Int J Cardiol; 2007 Jun 25; 119(1):80-2. PubMed ID: 17027106
    [Abstract] [Full Text] [Related]

  • 12. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N.
    J Med Assoc Thai; 2003 May 25; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [Abstract] [Full Text] [Related]

  • 13. Effect of urotensin II on skin microvessel tone in diabetic patients without heart failure or essential hypertension.
    Zomer E, de Ridder I, Kompa A, Komesaroff P, Gilbert R, Krum H.
    Clin Exp Pharmacol Physiol; 2008 Oct 25; 35(10):1147-50. PubMed ID: 18505448
    [Abstract] [Full Text] [Related]

  • 14. Increased plasma urotensin II levels in patients with diabetes mellitus.
    Totsune K, Takahashi K, Arihara Z, Sone M, Ito S, Murakami O.
    Clin Sci (Lond); 2003 Jan 25; 104(1):1-5. PubMed ID: 12519081
    [Abstract] [Full Text] [Related]

  • 15. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
    Mayer B, Holmer SR, Hengstenberg C, Lieb W, Pfeifer M, Schunkert H.
    Int J Cardiol; 2005 Aug 18; 103(2):182-6. PubMed ID: 16080978
    [Abstract] [Full Text] [Related]

  • 16. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T, Kato M, Ogino K, Osaki S, Igawa O, Hisatome I, Shigemasa C.
    J Card Fail; 2003 Aug 18; 9(4):318-24. PubMed ID: 13680553
    [Abstract] [Full Text] [Related]

  • 17. [Changes in plasma levels of adrenomedullin and cyclic adenosine monophosphate and their interrelation in patients with chronic heart failure].
    Yan QN, Li ZL, Wu HC, Chen YQ, Chen Q, Lu Q.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep 18; 22(9):803-5. PubMed ID: 12297436
    [Abstract] [Full Text] [Related]

  • 18. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure.
    Feola M, Menardi E, Ribichini F, Vado A, Deorsola A, Ferrero V, Visconti G, Milanese U, Uslenghi E.
    Med Sci Monit; 2003 Aug 18; 9(8):CR341-5. PubMed ID: 12942029
    [Abstract] [Full Text] [Related]

  • 19. Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure.
    Yin WH, Chen JW, Jen HL, Chiang MC, Huang WP, Feng AN, Young MS, Lin SJ.
    Am Heart J; 2004 May 18; 147(5):931-8. PubMed ID: 15131554
    [Abstract] [Full Text] [Related]

  • 20. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
    Yeh JL, Hsu JH, Dai ZK, Liou SF, Chen IJ, Wu JR.
    Int J Cardiol; 2005 Sep 15; 104(1):15-20. PubMed ID: 16055212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.